Molecular Mechanisms of Rhabdovirus Entry
弹状病毒进入的分子机制
基本信息
- 批准号:8602798
- 负责人:
- 金额:$ 41.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-01-01 至 2015-12-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAmino AcidsAntiviral AgentsBiochemicalBiologicalBiological ModelsBiological ProcessCell Culture TechniquesCell membraneCell surfaceCellsCellular MembraneChemicalsChimeric ProteinsClathrinCoupledEndocytic VesicleFlavivirusGTP-Binding ProteinsGeneticGenomeGlycoproteinsGrowthImageIn VitroIndividualInfectionInfluenza HemagglutininKineticsLipid BilayersMembraneMembrane FusionModelingMolecularMolecular ConformationMutationNucleic AcidsPathway interactionsProcessProteinsReagentResolutionRhabdoviridaeRibonucleoproteinsRoleSeriesSiteStagingStructureTechniquesTestingVesicular stomatitis Indiana virusViralViral Fusion ProteinsVirionVirusVirus DiseasesX-Ray Crystallographyconformational conversiondrug developmentenv Gene Productsfallsgenetic manipulationglycoprotein Ginhibitor/antagonistinsightinterestmutantnew technologyparticleprotein functionprototypepublic health relevanceresearch studyresponsetoolvirus core
项目摘要
DESCRIPTION (provided by applicant): Enveloped viruses must fuse viral and cellular membranes to transfer the viral nucleic acid into the host cell and initiate the infectious cycle. These viruses have evolved dedicated fusion proteins that catalyze this energetically unfavorable process. These fusion proteins fall into three classes as exemplified by influenza hemagglutinin (class I), flavivirus envelope proteins (class II) and rhabdovirus glycoproteins (class III). In response to specific triggers, these fusion proteins undergo dramatic conformational changes that bring the viral and target membranes into close proximity, lowering the energy barrier to membrane fusion. The mechanism by which class III proteins accomplish this is the least well understood. Vesicular stomatitis virus (VSV), a prototype of the Rhabdoviridae, is the ideal model to study how class III fusion machines function as the structure of its single attachment and fusion glycoprotein was recently solved by X-ray crystallography in both pre and post fusion forms. Our long term objectives are to understand how VSV delivers its 286 MDa ribonucleoprotein core into cells to initiate the process of infection. Membrane fusion is a central step of this process. Here we have capitalized on the facile genetics of VSV and its robust growth in cell culture to develop new technologies to study the process of membrane fusion and viral entry. Our underlying hypothesis is that specific pH triggered conformational transitions in G drive the initial steps of membrane fusion, but that interactions between multiple G protein trimers are required to accomplish delivery of the ribonucleoprotein core of the virus across the membrane. We will examine this hypothesis in three interrelated aims. In specific aim 1, we will use genetic and biochemical approaches to determine the requirements in G for pH triggered conformational change, membrane fusion and viral infectivity. In specific aim 2, we will use high-resolution single particle imaging approaches to probe the relationships between hemifusion, fusion pore formation and transfer of the RNP across a lipid bilayer in vitro. In specific aim 3, we will use high resolution single particle imaging to determine the site of membrane fusion and RNP release in cells. Completion of these studies will reveal how a class III fusion protein functions to accomplish delivery of the viral contents into the cell. Consequently, these studies will provide new mechanistic insights into the process of enveloped virus membrane fusion and endocytic transport.
描述(由申请人提供):被包裹的病毒必须融合病毒和细胞膜,将病毒核酸转移到宿主细胞中,并启动感染循环。这些病毒进化出了专门的融合蛋白,催化了这一不利的能量过程。这些融合蛋白分为三类,如流感血凝素(I类)、黄病毒囊膜蛋白(II类)和横纹病毒糖蛋白(III类)。作为对特定触发因素的反应,这些融合蛋白经历了戏剧性的构象变化,使病毒和靶膜更接近,降低了膜融合的能量障碍。III类蛋白完成这一任务的机制是最不为人所知的。水泡性口炎病毒(VSV)是横纹病毒科的一个原型,是研究III类融合机如何发挥作用的理想模型,因为它的单附着和融合糖蛋白的结构最近通过X射线结晶学在融合前和融合后被解决。我们的长期目标是了解VSV如何将其286丙二醛核糖核蛋白核心运送到细胞内,以启动感染过程。膜融合是这一过程的中心步骤。在这里,我们利用VSV简单的遗传学和它在细胞培养中的强劲生长来开发新的技术来研究膜融合和病毒进入的过程。我们的基本假设是,特定的pH触发G的构象转变驱动膜融合的初始步骤,但需要多个G蛋白三聚体之间的相互作用才能完成病毒核糖核蛋白核心的跨膜递送。我们将从三个相互关联的目标来检验这一假设。在具体目标1中,我们将使用遗传和生化方法来确定G对pH引发的构象变化、膜融合和病毒感染性的需求。在特定的目标2中,我们将使用高分辨率的单粒子成像方法来探索体外半融合、融合孔形成和RNP跨脂质双层转移之间的关系。在具体目标3中,我们将使用高分辨率单粒子成像来确定细胞内膜融合和RNP释放的位置。这些研究的完成将揭示III类融合蛋白如何发挥作用,完成病毒内容物进入细胞的输送。因此,这些研究将为包膜病毒膜融合和胞内转运过程提供新的机制见解。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Infectious Entry Pathway Mediated by the Human Endogenous Retrovirus K Envelope Protein.
由人内源性逆转录病毒 K 包膜蛋白介导的感染进入途径。
- DOI:10.1128/jvi.03136-15
- 发表时间:2016
- 期刊:
- 影响因子:5.4
- 作者:Robinson,LindseyR;Whelan,SeanPJ
- 通讯作者:Whelan,SeanPJ
Virus entry. Lassa virus entry requires a trigger-induced receptor switch.
- DOI:10.1126/science.1252480
- 发表时间:2014-06-27
- 期刊:
- 影响因子:0
- 作者:Jae LT;Raaben M;Herbert AS;Kuehne AI;Wirchnianski AS;Soh TK;Stubbs SH;Janssen H;Damme M;Saftig P;Whelan SP;Dye JM;Brummelkamp TR
- 通讯作者:Brummelkamp TR
Rabies Internalizes into Primary Peripheral Neurons via Clathrin Coated Pits and Requires Fusion at the Cell Body.
- DOI:10.1371/journal.ppat.1005753
- 发表时间:2016-07
- 期刊:
- 影响因子:6.7
- 作者:Piccinotti S;Whelan SP
- 通讯作者:Whelan SP
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sean PJ Whelan其他文献
Sean PJ Whelan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sean PJ Whelan', 18)}}的其他基金
2015 Viruses and Cells Gordon Research Conference
2015年病毒与细胞戈登研究会议
- 批准号:
8985372 - 财政年份:2015
- 资助金额:
$ 41.33万 - 项目类别:
Small molecule inhibitors of enveloped virus entry
有包膜病毒进入的小分子抑制剂
- 批准号:
8810214 - 财政年份:2014
- 资助金额:
$ 41.33万 - 项目类别:
Small molecule inhibitors of enveloped virus entry
有包膜病毒进入的小分子抑制剂
- 批准号:
9221939 - 财政年份:2014
- 资助金额:
$ 41.33万 - 项目类别:
Small molecule inhibitors of enveloped virus entry
有包膜病毒进入的小分子抑制剂
- 批准号:
9011996 - 财政年份:2014
- 资助金额:
$ 41.33万 - 项目类别:
Small molecule inhibitors of enveloped virus entry
有包膜病毒进入的小分子抑制剂
- 批准号:
8641840 - 财政年份:2014
- 资助金额:
$ 41.33万 - 项目类别:
Novel antiviral targets in Ebola and Marburg virus polymerases
埃博拉和马尔堡病毒聚合酶的新抗病毒靶点
- 批准号:
8233441 - 财政年份:2011
- 资助金额:
$ 41.33万 - 项目类别:
相似海外基金
Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
- 批准号:
BB/Y006380/1 - 财政年份:2024
- 资助金额:
$ 41.33万 - 项目类别:
Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
- 批准号:
24K17112 - 财政年份:2024
- 资助金额:
$ 41.33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
- 批准号:
2300890 - 财政年份:2023
- 资助金额:
$ 41.33万 - 项目类别:
Continuing Grant
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
- 批准号:
23K06918 - 财政年份:2023
- 资助金额:
$ 41.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
- 批准号:
23K05758 - 财政年份:2023
- 资助金额:
$ 41.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
- 批准号:
23K04668 - 财政年份:2023
- 资助金额:
$ 41.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
- 批准号:
2888395 - 财政年份:2023
- 资助金额:
$ 41.33万 - 项目类别:
Studentship
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
- 批准号:
10761044 - 财政年份:2023
- 资助金额:
$ 41.33万 - 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
- 批准号:
10728925 - 财政年份:2023
- 资助金额:
$ 41.33万 - 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
- 批准号:
10757309 - 财政年份:2023
- 资助金额:
$ 41.33万 - 项目类别:














{{item.name}}会员




